• Home
  • Search Results
  • Construction of Self-activated Cascade Metal-Organic Framework/Enzyme Hybrid Nanoreactors as Antibacterial Agents.

Construction of Self-activated Cascade Metal-Organic Framework/Enzyme Hybrid Nanoreactors as Antibacterial Agents.

Colloids and surfaces. B, Biointerfaces (2020-04-24)
Tong Li, Huiqiang Qiu, Na Liu, Jiawei Li, Yuheng Bao, Weijun Tong
ABSTRACT

Metal organic frameworks (MOFs) served as peroxidase-like artificial enzymes have been recently adopted for wide applications including therapy, pollution degradation, biosensing and so on. However, most of MOFs mimicking peroxidase cannot perform with the utmost efficiency under certain biological circumstances, such as bacterial infections. This is mainly because that the peroxidase-like MOFs exhibit highest activity at pH of 3-4, while bacterial infections cannot lower the environmental pH to the optimal value. This problem significantly restrains the therapy effect. Herein, self-activated cascade MOF/enzyme hybrid nanoreactors (MIL@GOx-MIL NRs) based on MIL (Materials of Institute Lavoisier) and GOx (Glucose oxidase) were successfully constructed through a two-step procedure. GOx was successfully loaded in the MIL shells and onto their surface as well. The GOx can catalyze the production of gluconic acid that reduces the pH value to around 4, at which the MIL@GOx-MIL NRs perform the highest cascade reaction activity. The continually produced hydrogen peroxide (H2O2) can be subsequently catalyzed by MIL NPs to generate highly toxic hydroxyl radicals (HO•) for antibacterial application. Thus, MIL@GOx-MIL NRs can significantly inhibit methicillin-resistant staphylococcus aureus (MRSA) growth and biofilm formation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Aminoterephthalic acid, 99%
Sigma-Aldrich
2,3-Lutidine, 99%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.